Skip to main content

Closed

PASG: Passage Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-238.3%

Financially safe

Stretched

Debt / equity0.49×

Interest coverage0.0×

Current ratio1.73×

Passage Bio, Inc.

PASGNASDAQ Global Select·USD·Closed

Passage Bio, Inc.

PASGNASDAQ·USD·Closed

$4.47

−0.45%

$4.47

−$0.02 (0.45%)

52W Range

7thpctl

Volume

0.06×avg

Mkt Cap

14.36MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.06×avg

Market Cap

14.36MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings